Skip to Main Content

Paper Details

Pharmacogenomic Analyses Implicate B Cell Developmental Status and <i>MKL1</i> as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy.
Cells
0
2023
Anti-CD20 Monoclonal Antibody, B, B Cell, B cell, B cell disorders, CD20, CD20 mAbs, Ig isotype, IgG, IgG cells, LCLs, MKL1, anti-CD20 mAb, cell lines, immunoglobulin, lymphoblastoid cell lines, novel gene candidates, obinutuzumab, ofatumumab, patient, prednisolone, resistant lines, rituximab, rs58600101, shRNA, transcript
Author NameAffiliation
David M ReifNational Institute of Environmental Health Sciences
Alison A Motsinger-ReifNational Institute of Environmental Health Sciences
Howard L McLeodCenter for Precision Medicine and Functional Genomics, Utah Tech University, 225 South University Ave
Howard L McLeodCenter for Precision Medicine and Functional Genomics, Utah Tech University, 225 South University Ave
  • 1 - 4

Datasets

Release 1.2